Tevogen Bio Holdings Inc.
TVGN
$0.9922
-$0.0178-1.76%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | -60.51% | 39.11% | -185.78% | 410.14% | 6.99% |
| Total Depreciation and Amortization | 1.77% | 1.70% | 1.73% | -2.58% | 7.80% |
| Total Amortization of Deferred Charges | -- | -- | -100.00% | -- | -- |
| Total Other Non-Cash Items | 150.84% | -39.95% | 135.07% | -1,014.65% | 2.72% |
| Change in Net Operating Assets | 34.79% | -183.58% | 165.41% | 860.35% | -115.79% |
| Cash from Operations | 19.90% | -27.57% | -37.84% | -9.48% | -9.81% |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -- | -- | -- | -- |
| Total Debt Issued | -100.00% | -- | -- | -- | -69.57% |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -50.00% | 42.86% | 27.27% | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -100.00% | 217.15% | 136.15% |
| Cash from Financing | -60.00% | 78.57% | 15.26% | 475.25% | -55.55% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -187.65% | 754.96% | -168.74% | 117.08% | -82.85% |